Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | MANE | KNSA | ||
| Company | Crispr Therapeutics Ag | Veradermics Incorporated | Kiniksa Pharmaceuticals International Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 50.65 | 123.12 | 61.49 | ||
| High | 50.78 | 125.17 | 61.71 | ||
| Low | 47.87 | 104.46 | 60.26 | ||
| Latest | 48.57 | 105.83 | 61.11 | ||
| Change | -2.80 | -17.87 | -0.58 | ||
| % Change | -5.45% | -14.45% | -0.94% | ||
| Volume | 2,101,200 | 1,455,300 | 473,800 | ||
| 20-Day Average Volume | 1,805,165 | 863,450 | 1,065,810 | ||
| Previous Close | 51.37 | 123.70 | 61.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.86 | 115.60 | 61.21 | ||
| 20-Day Raw Stochastic | 4.52% | 42.78% | 56.77% | ||
| 20-Day Relative Strength | 41.71 | 48.85 | 55.89 | ||
| Weighted Alpha | -25.82 | N/A | +88.38 | ||
| Today's Opinion | 56% Sell | N/A | 88% Buy | ||
| Previous Opinion | 48% Sell | N/A | 100% Buy | ||
| Last Month's Opinion | 32% Sell | N/A | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.79% since 07/09/26 | -15.27% since 07/09/26 | -6.53% since 07/09/26 | ||
| Low | 47.87 on 07/16/26 | 104.46 on 07/16/26 | 60.13 on 07/14/26 | ||
| High | 56.65 on 07/10/26 | 129.80 on 07/15/26 | 65.71 on 07/10/26 | ||
| 1-Month | |||||
| %Chg | -6.63% since 06/16/26 | +16.36% since 06/16/26 | +16.85% since 06/16/26 | ||
| Low | 47.87 on 07/16/26 | 86.83 on 06/18/26 | 52.68 on 06/17/26 | ||
| High | 63.45 on 07/06/26 | 131.24 on 07/01/26 | 67.53 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | -12.83% since 04/16/26 | +42.78% since 04/16/26 | +34.84% since 04/16/26 | ||
| Low | 46.92 on 05/19/26 | 65.80 on 04/24/26 | 41.49 on 04/21/26 | ||
| High | 63.45 on 07/06/26 | 131.24 on 07/01/26 | 67.53 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | -9.23% since 01/16/26 | N/A since 02/04/26 | +55.06% since 01/16/26 | ||
| Low | 44.12 on 03/30/26 | 32.00 on 02/04/26 | 38.40 on 01/20/26 | ||
| High | 63.45 on 07/06/26 | 131.24 on 07/01/26 | 67.53 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,954,585 | 5,168,061 | 4,746,306 | ||
| Shares Outstanding, K | 96,449 | 41,779 | 76,938 | ||
| Annual Sales | 3,510,000 | 0 | 677,560,000 | ||
| Annual Net Income | -581,600,000 | -70,000,000 | 59,010,000 | ||
| Last Quarter Sales | 1,460,000 | 0 | 214,270,000 | ||
| Last Quarter Net Income | -122,930,000 | -27,230,000 | 22,590,000 | ||
| 60-Month Beta | 1.71 | N/A | 0.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.28 on 05/04/26 | -1.32 on 05/12/26 | 0.27 on 04/28/26 | ||
| Earnings Date | 08/03/26 | 08/11/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 68.87 | ||